Lactic acidosis type B: A serious side effect during antiretroviral therapy;Lactatacidose type B: En livstruende bivirkning til antiretroviral behandling

Ugeskrift for Laeger

Volumn 162, Issue 35, 2000, Pages 4664-4665

  Justesen, U S ^a   Pedersen, C ^a  

^a Infektionsmedicinsk Sektion   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BICARBONATE; LAMIVUDINE; PROTEINASE INHIBITOR; STAVUDINE;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HEARING IMPAIRMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTIC ACIDOSIS;

ACIDOSIS, LACTIC; ADULT; ANTI-HIV AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; LAMIVUDINE; STAVUDINE;

EID: 0034726504     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Lactic acidosis complicating the acquired immunodeficiency syndrome
2. Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy
3. Hepatic steatosis and lactic acidosis associated with stavudine treatment in an HIV patient: A case report
4. Riboflavin to treat nucleoside analogue-induced lactic acidosis